Pharmacy Faculty Research
A Randomized, Placebo-controlled, Double-blind, Dose-escalation Phase I Study of the Safety, Tolerability and Pharmacokinetics of a Single Intravenous Dose of ETI-204 (AnthimTM) and its Potential Interaction with Ciprofloxacin (AH-101)
Role
Pharmacist
Research Period
2005-2006
Sponsor
Elusys Pharmaceuticals
Location
Pine Brook, NJ
Recommended Citation
Huston, Jeffrey L., "A Randomized, Placebo-controlled, Double-blind, Dose-escalation Phase I Study of the Safety, Tolerability and Pharmacokinetics of a Single Intravenous Dose of ETI-204 (AnthimTM) and its Potential Interaction with Ciprofloxacin (AH-101)" (2005). Pharmacy Faculty Research. 13.
https://digitalcommons.cedarville.edu/pharmacy_research/13
